Belite Bio (BLTE) Receivables - Other (2022 - 2025)
Belite Bio's (BLTE) quarterly Receivables - Other came in at $700000.0 in Q4 2025, up 21.74% year-on-year from $575000.0 in Q4 2024, and up 11766.67% quarter-over-quarter from -$6000.0 in Q3 2025.
Belite Bio (BLTE) Receivables - Other (2022 - 2025) Analysis & Trends
Belite Bio's Receivables - Other history runs 4 years deep, the most recent figure standing at $700000.0 for Q4 2025.
- On a quarterly basis, Receivables - Other rose 21.74% year-over-year to $700000.0 in Q4 2025; TTM through Dec 2025 was $700000.0, a 21.74% increase from a year earlier, with the FY2025 full-year figure at $700000.0, up 21.74% from the prior year.
- Receivables - Other advanced to $700000.0 in Q4 2025 per BLTE's latest filing, from -$6000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $818000.0 in Q4 2023 and bottomed at -$6000.0 in Q3 2025.
- The 4-year median for Receivables - Other is $315500.0 (2024), against an average of $357500.0.
- Across the five-year window, Receivables - Other jumped 40800.0% in 2023 and sank 110.71% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $2000.0 in 2022, then soared by 40800.0% to $818000.0 in 2023, then declined by 29.71% to $575000.0 in 2024, then advanced by 21.74% to $700000.0 in 2025.
- Per Business Quant, the three latest BLTE Receivables - Other figures stand at $700000.0 (Q4 2025), -$6000.0 (Q3 2025), and $575000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Dec 31, 2023 | 818,000.00 |
| Dec 31, 2023 | 818,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |